Jubilant Biosys Limited Announces New Chemistry Innovation Research Center to Support Expanded Discovery Chemistry and in-vitro ADME Services for Clients like Turning Point Therapeutics

Jubilant Biosys Limited announced today, an expansion of its facilities to support its discovery chemistry and in-vitro ADME Service offerings. Jubilant Biosys provides services for Turning Point Therapeutics Inc. for multiple small molecule oncology research programs. Turning Point is a precision oncology company developing next-generation therapies that target genetic drivers of cancer. Services for Turning Point Therapeutics Inc. […]

thaipr.net

15 พ.ย. 64
1 2,657 2,658 2,659 2,660 2,661 3,340